The present disclosure provides a composition and methods for preventing, reducing, or eliminating a
mastitis infection in a bovine animal. The composition includes an inhibitory composition in an amount effective to inhibit the growth of infectious
mastitis pathogens in a mammary
system of the bovine animal, where the inhibitory composition includes a
microbial composition or an extract of one or more microbes of a mammary
system-associated microbiota of healthy bovines, including Anaerocolumna aminovalerica, Bacillus glycinifermentans,
Bacillus licheniformis, Bacillus pumilis, Bacillus sonorensis, Bacillus_AY sp002271785, Bacillus butanolivorans,
Brevibacillus borstelensis,
Brevibacterium epidermis,
Clostridium aerotolerans,
Corynebacterium sp.,
Corynebacterium xerosis, Cutibacterium acnes, Cytobacillus kochii, Dietzia sp.,
Enterococcus aquimarinus,
Enterococcus faecalis,
Enterococcus_A pseudoavium, Facklamia sp., Facklamia tabacinasalis, Hungatella, Lacrimispora sp., Lacrimispora algidixylanolytica, Metabacillus niabensis,
Micrococcus luteus,
Paenibacillus pabuli, Paraclostridium bifermentans, Peribacillus simplex, Populibacterium corticicola, Timonella sp., Tissierella creatinini, and
Weissella jogaejeotgali, or any combinations thereof.